Citi resumed coverage of Playtika with a Neutral rating and $11 price target. The analyst sees continued upside from future acquisitions, but also potential risks from payer conversion rates falling from pandemic-highs. As such, the firm continues to view Playtika’s risk/reward as relatively balanced at current levels.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on PLTK: